Don’t forget how severe varicella can be—complications of varicella in children in a defined Polish population  by Gowin, Ewelina et al.
International Journal of Infectious Diseases 17 (2013) e485–e489Don’t forget how severe varicella can be—complications of varicella in children
in a deﬁned Polish population
Ewelina Gowin a,*, Jacek Wysocki b, Michał Michalak c
a Family Medicine Department, Poznan University of Medical Sciences, 49, Przybyszewskiego Str., 60-355 Poznan, Poland
bDepartment of Health Promotion, Poznan University of Medical Sciences, Poznan, Poland
cDepartment of Biostatistics, Poznan University of Medical Sciences, Poznan, Poland
A R T I C L E I N F O
Article history:
Received 17 October 2012
Received in revised form 21 November 2012
Accepted 29 November 2012







S U M M A R Y
Background: This study aimed to analyze the causes of hospitalization in children with varicella, based on
a deﬁned Polish population.
Methods: This was a retrospective analysis of causes of hospitalization in children under 18 years of age
with varicella, treated on the Infectious Diseases Ward of the Children’s Hospital in Poznan, Poland from
January 2007 to June 2012. The ward serves almost the entire child population of the Greater Poland
region (10% of the Polish population – almost 600 000 children). The analysis was based on hospital
records. Patients were identiﬁed using the International Classiﬁcation of Diseases Tenth Revision (ICD-
10) codes. The case deﬁnition consisted of physical evidence of varicella.
Results: A total of 224 children were hospitalized for varicella complications. The median age of
admitted patients was 37.5 months (range 6 days to 17 years). Rates of hospitalization decreased with
age. The highest rates were among children during their ﬁrst year. Ninety-two percent of children were
healthy prior to hospitalization (no chronic diseases). The most common complications were respiratory
tract infections (26%), followed by skin infections (21%) and neurological symptoms (18%). Twenty-ﬁve
patients (11%) had more than one complication. The most common coexisting conditions were
dehydration and otitis media.
Conclusions: The results presented here serve to remind us that varicella may to lead to severe
complications in unvaccinated children and adolescents, and demonstrate the beneﬁts of varicella
vaccination. Most children hospitalized with varicella were immunologically healthy. Meningitis was
more common in older children (>6 years of age). Streptococcus pyogenes was the most commonly
identiﬁed bacterial pathogen.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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According to a 2010 varicella surveillance report from 18
European countries, Poland had the highest incidence of varicel-
la.1 Each year there are approximately 150 000 cases of varicella in
Poland (Table 1).2,3 An increase in the number of cases is noted
every 3–4 years, with an observable seasonal pattern.2–4 In
temperate climates, more cases are seen in the late spring and
early summer. Most cases are in children younger than 15 years,
and the highest incidence rate is in children aged 1–4 years.1,2,5
Despite a common perception of varicella infection as a highly
contagious but harmless childhood condition, one cannot forget
that potentially severe complications or painful herpes zoster
relapses may occur. Each year in Poland around 0.5% of patients
with varicella require hospitalization.2 This is similar to the* Corresponding author. Tel.: +48 605 723 017; fax: +48 61 869 11 43.
E-mail address: ewego@poczta.onet.pl (E. Gowin).
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http://dx.doi.org/10.1016/j.ijid.2012.11.024percentage during the pre-vaccine era in the USA, when there
were 4 million varicella cases annually and 0.3% required
hospitalization (13 000 cases).6Varicella generates substantial
costs for the healthcare system, either through the treatment of
complications or as indirect costs as a result of parent workdays
lost while caring for their sick child. The varicella vaccine was
developed in Japan in the 1970s. The efﬁcacy of the two-dose
schedule is 97%.6–8 In the USA, the vaccine has been administered
routinely since 1995 and has resulted in a 90% reduction in
morbidity.6–8
Most of those who are against vaccination deny the usefulness
of the varicella vaccination. The decrease in the rates of varicella in
unvaccinated children is a demonstration of herd immunity and is
a welcome effect of the vaccine. Parents and sometimes even
doctors with less personal experience of the disease may change
perceptions of the risk of varicella. Analysis of the causes of
hospitalization in patients with varicella from a population with a
high incidence reminds us that varicella is a disease with
potentially severe complications.ses. Published by Elsevier Ltd. All rights reserved.
Table 1
Varicella in Poland and the Greater Poland region 2007–2011
2007 2008 2009 2010 2011
Poland
Number of cases 160 174 129 662 140 115 183 446 172 855
Incidence/100 000 420.2 340.2 367.2 480.4 452.7
Greater Poland region
Number of cases 18 371 12 925 15 534 19 322 17 360
Incidence/100 000 543.2 381 455.77 565.93 507.69
Number of hospitalizations 96 67 80 101 110
% of admitted patients with varicella 0.52 0.52 0.51 0.52 0.63
Number of hospitalizations in the Children’s Hospital in Poznan 27 14 35 44 50
Table 2




















E. Gowin et al. / International Journal of Infectious Diseases 17 (2013) e485–e489e486The aim of this study was to analyze the causes of hospitaliza-
tion in children with varicella, based on a deﬁned Polish
population.
2. Materials and methods
This was a retrospective analysis of the causes of hospitalization
in children younger than 18 years of age with varicella, treated on
the Infectious Diseases Ward of the Children’s Hospital in Poznan,
Poland from January 2007 to June 2012. This infectious diseases
ward serves almost the entire child population of the Greater
Poland region. Inhabitants of the Greater Poland region form 10% of
the Polish population (almost 600 000 children). All children in
Poland have mandatory health care insurance.
The analysis was based on hospital records. Patients were
identiﬁed using the International Classiﬁcation of Diseases Tenth
Revision (ICD-10) codes. The case deﬁnition consisted of physical
evidence of varicella. A complication was deﬁned as any health
condition that required hospitalization. The diagnosis of varicella
was based on clinical symptoms and signs. Pneumonia was
diagnosed based on chest X-ray; meningitis/meningoencephalitis
was diagnosed based on cerebrospinal ﬂuid analysis; ataxia was
clinically diagnosed. Bacterial cultures were obtained for each case
suspected of a bacterial suprainfection. Thrombocytopenia was
deﬁned as a platelet count of <100  109/l and anemia as
hemoglobin <6.2 mmol/l. Hepatitis was deﬁned as alanine
aminotransferase (ALT) and aspartate aminotransferase (AST)
levels more than twice the upper limit of the normal range.
Chronic disease was deﬁned as any disease requiring ongoing
medical treatment. The reason for and length of hospitalization,
patient’s age, health status, chronic diseases, and duration of
varicella symptoms at the time of admission were analyzed.
2.1. Statistical analysis
The relationship between analyzed data was assessed using
Pearson’s linear correlation coefﬁcient. The signiﬁcance of the
obtained coefﬁcient was checked by Student’s t-test. Comparisons
between the analyzed groups were done by analysis of variance. In
cases where a signiﬁcant difference was observed, a post-hoc
Tukey test was performed in order to determine homogeneous
groups. Normality of the analyzed data was checked by Shapiro–
Wilk test; second assumption – homogeneity of variances – was
analyzed by Levene’s test. Data were analyzed using statistical
package Statistica 10 (StatSoft Inc.). All tests were considered
signiﬁcant at p < 0.05.
3. Results
Over the study period from January 2007 to June 2012, 224
children were hospitalized on the Infectious Diseases Ward of the
Children’s Hospital in Poznan for varicella complications. A total of249 complications were observed (Table 2). The number of
hospitalizations in each year is shown in Table 1. A seasonal
pattern was observed, with 82% of hospitalizations in the period
from December through June and the highest admission rate from
April to June. This seasonality was evident in each year of the study
period and in all age groups. The median length of hospitalization
was 6 days (range 2–25 days).
The median age of admitted patients was 37.5 months (range 6
days to 17 years). Rates of varicella-related hospitalizations
decreased with age. The highest rates were among children during
their ﬁrst year of life. Children younger than 4 years comprised 63%
of hospitalized patients. Six cases of varicella in newborns were
observed, with half of these infections transmitted from the
mother. Statistically signiﬁcant differences in the age of children
with different complications were observed (for details see
Figure 1 and Table 3).
The male to female ratio of hospitalized children was 1.2:1 (121
males and 103 females). Ninety-two percent of children were
healthy prior to hospitalization (no chronic diseases). A history of
asthma was obtained from six patients, and all of them
experienced complications in the respiratory tract. Atopic derma-
titis was noted in ﬁve patients and epilepsy in ﬁve. There was one
patient with nephrotic syndrome, one with rheumatoid arthritis,
and one with congenital heart failure. The median time between
the onset of varicella exanthema and admission to hospital was 3
days (range 0–14 days).
The most frequent complication was respiratory tract infection
(details in Tables 4 and 5). Radiographically proven pneumonia
was diagnosed in 35 patients (16%). This was the most frequent
complication in the youngest group. Other respiratory tract
infections were bronchitis, otitis media, and laryngitis.
Figure 1. Frequency of most common complications in the different age groups.
Table 4
Varicella complications (n = 249) observed during the hospitalizations of 224
patients







Pneumonia 35 15.6 14.1
Bronchitis 15 6.7 6.0
Otitis media 7 3.1 2.8
Laryngitis 2 0.9 0.8
Skin complications 47 21.0 18.9
Pyogenic skin infection 17 7.6 6.8
Hemorrhagic varicella 3 1.3 1.2
Numerous skin changes 23 10.3 9.3
Urticaria 1 0.4 0.4
Erythema multiforme 1 0.4 0.4
Sepsis 2 0.9 0.9
Neurological complications 42 18.7 16.8
Meningoencephalitis 12 5 4.8
Ataxia 7 3.1 2.8
Seizures 9 4.0 3.6
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pyogenic dermatitis were the next most common reasons for
hospitalization. A bacterial etiology was established in 13 cases
(seven cases of Streptococcus pyogenes and six of Staphylococcus
aureus). Over the study period there were two cases of sepsis
(0.9%). Blood and skin cultures were positive for S. pyogenes. Sepsis
appeared on the ﬁfth day of varicella infection. Both children were
immunocompetent, aged 50 and 72 months.
Central nervous system complications were observed in 38
patients (17%): 12 had meningoencephalitis, seven had ataxia, and
nine had seizures. Patients with meningoencephalitis were
signiﬁcantly older than the rest of the group (p < 0.001) (Table 3).
Twenty-ﬁve patients (11%) had more than one complication.
The most frequent coexisting conditions were dehydration and
otitis media. Other reasons for admission are described in Table 4.
The distribution of reasons for admission in the different age
groups is shown in Figure 1.
4. Discussion
The number of hospitalizations over the study period was
different in the different years studied, and reﬂects changes in
incidence rates. The lowest incidence rate was in 2008. The
observed seasonal pattern of hospitalization reﬂects the seasonal
incidence that is commonly observed.4 Compared with other data
from the literature, a group of 224 patients hospitalized over a
period of 5 years is quite signiﬁcant.9–11Table 3
Mean age of patients with the most common complications
Age, years, mean  SD
Pneumonia 2.54a 3.51




a,b Groups followed by the same letter do not differ signiﬁcantly.The median age of 3.12 years for all the patients hospitalized
with varicella corresponds well with the literature data.9,12–14 In
our study, most of the admitted patients were aged younger than 4
years and 90% of the patients were younger than 10 years of age.
This reﬂects the epidemiological trend in varicella morbidity. The
varicella virus is one of the most contagious viruses, and even
treatment with acyclovir does not stop droplet spreading. TheSyncope 10 4.5 4.0
Vertigo 1 0.4 0.4
Headache 3 1.3 1.2
Hematologic complications 17 7.6 6.8
Anemia 8 3.6 3.2
Thrombocytopenia 5 2.2 2.0
Henoch–Sch 1 0.4 0.4
Bleeding diathesis 3 1.3 1.2
Hepatitis 5 2.2 2.0
Dehydration 45 20.1 18.1
Arthritis 1 0.4 0.4
Severe varicella 33 15 13
Total 249
Table 5
Detailed information on complications
Respiratory tract complications (n = 59) Pneumonia Otitis media Bronchitis
Number of patients 35 7 15
Mean age, months 34 21 19
Sex, female/male 21/14 1/6 6/9
Mean length of hospitalization, days 10 9 9
Varicella duration at admission, days 3 5 2
Risk factors 5 (asthma in 3) 0 2
Co-existing complications 6 (pyogenic skin infection, hepatitis, seizures, anemia) 3 (dehydration) 2 (dehydration, hepatitis)
Neurological complications (n = 42) Ataxia Meningoencephalitis Seizures
Number of patients 7 12 9
Mean age, months 73 109 42
Sex, female/male 4/3 6/6 3/6
Mean length of hospitalization, days 9,4 13 6
Varicella duration at the admission, days 5.7 5.8 3
Risk factors 5 0 0
Co-existing complications 6 (pyogenic skin infection, hepatitis, seizures, anemia) 1 (anemia) 0
Hematologic complications (n = 17) Anemia Thrombocytopenia
Number of patients 8 5
Mean age, months 21 44
Sex, female/male 4/3 3/2
Mean length of hospitalization, days 9 6
Varicella duration at the admission, days 3 4
Risk factors 1 0
Co-existing complications 3 (dehydration, bronchitis, pneumonia) 0
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contacts, so contact usually results in infection. In past years the
peak incidence occurred in early school-age children. Now, due to
the common use of preschool care facilities, most children have
contact with the virus earlier in their lives. The highest
hospitalization rates were during the ﬁrst year of life, which has
also been observed in other studies.1,15
The type of complication depends on patient age. The youngest
children had pneumonia, and the oldest meningitis/meningoen-
cephalitis. This can be explained by the hypothesis that
neurological symptoms such as encephalitis and meningitis are
caused by autoimmune reactions triggered by the presence of the
virus. Progression of neurologic symptoms is observed even on
acyclovir treatment, and improvement occurs after the adminis-
tration of steroids. PCR of cerebral ﬂuid is negative. Older children
are thought to be more susceptible to antibody-mediated
inﬂammatory reactions, whereas younger, less immunocompetent
patients are more frequently affected by bacterial suprainfections
of the skin or the respiratory tract.16,17
The most commonly observed complications were infections of
the respiratory tract. This is consistent with US data from the pre-
vaccination era.15,16 Respiratory tract infections were present in
younger children, and usually developed at the beginning of the
varicella infection.16
The high frequency of respiratory tract complications reﬂects
the biology of the virus. The virus enters the host through the
respiratory tract and then spreads in the bloodstream. A cytopathic
effect of the varicella virus on the alveolar epithelium causes
pneumonia. Desquamated alveolar cells contribute to poor gas
exchange. In the group analyzed in this study there were no cases
of respiratory insufﬁciency, which can be attributed to the
introduction of acyclovir therapy early in the course of the disease.
Based on the literature, it is known that the most common
complications of varicella are bacterial skin infections (observed in
5% of our patients).9,10,17,18 The low rate of hospitalization due to
bacterial skin infections can be explained by the fact than in
countries with high hygiene standards, most skin infections can be
treated in outpatient clinics and only the most severe cases lead to
hospitalization. The most frequently identiﬁed bacterial pathogen
was S. pyogenes. An increase in S. pyogenes skin infections has beenobserved since the 1990s; S. aureus was the leading cause prior to
that time.10,12,18
Hematological complications are observed in 1–2% of children
with varicella.19 Patients usually remain asymptomatic. Like many
other thrombocytopenias and anemias during viral infections,
those in patients with varicella are transient and require no
treatment. Laboratory tests are not performed routinely in patients
with varicella. It can therefore be assumed that the number of
hematological complications is underestimated, because only a
few patients require hospitalization.
The manifestation of neurological symptoms is very worrisome
for caregivers, so they usually seek medical help immediately. In
our study, children with neurological complications, especially
cerebellar ataxia or meningoencephalitis, were admitted to
hospital later in the course of their disease than children with
other complications. This is consistent with the literature data.20,21
The incidence of neurological complications among hospitalized
children varies from 8% to 38%.20,21 There are some studies in
which neurological complications are the most frequent cause of
hospitalization.12 The percentage in admitted patients depends on
their age group. A higher percentage of neurological complications
can be observed in the partly vaccinated population as a
consequence of the shift of incidence to older groups. In the
studied group, all cases of meningitis/meningoencephalitis oc-
curred in children older than 57 months, and 87.5% in children
older than 6.5 years.
In our study, 11% of patients had more than one complication. The
most common co-existing condition was dehydration, which was
present in all age groups. Difﬁculties in oral intake due to mucosal
involvement, symptoms of gastroenteritis, and fever all together
may cause dehydration. Five cases of hepatitis were observed, but no
Reye’s syndrome, as salicylates are withheld from children and only
a few cases of Reye’s syndrome have been observed since
the1990s.22
The low number of patients with immunodeﬁciencies, similar
to the data presented in studies from other countries, can be
explained by the effectiveness of preventive measures such as
acyclovir therapy or vaccinations.1,23 Children with previously
diagnosed immunodeﬁciencies usually receive oral acyclovir at the
level of ambulatory care. In Poland, since 2009, vaccinations for
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compulsory (free of charge).
Vaccinations against varicella are an efﬁcient way to ﬁght
varicella infections. Based on German and US examples, the
efﬁcacy and cost-effectiveness of vaccinations has been demon-
strated, with vaccination of more than 75% of the target population
reducing morbidity in 80% of that population.15,18,19,24 With lower
coverage, the average age of infection, as well as the number of
severe cases, will increase.7 That is why the World Health
Organization (WHO) advises vaccinations against varicella only
when high coverage (more than 75% of the target population) is
possible. The coverage of the measles, mumps, and rubella (MMR)
vaccine is used as a predictive measure. Poland is a good candidate
for population varicella vaccination because MMR vaccine uptake
is greater than 75%.2
In a situation in which a low coverage is achieved, vaccination
may lead to a shift of the disease to older age groups. This
phenomenon has been observed in the case of MMR vaccina-
tions.1,19 Herd immunity, which is good for diseases that are
dangerous during the early stages of life, is harmful in the case of
varicella. Infection in older age groups is connected to a greater risk
of complications, especially neurological.
Financial barriers are an important factor in determining the
uptake of a vaccine. Reducing ﬁnancial barriers is an effective
strategy for increasing vaccination coverage rates.
The children in our study group were not vaccinated. In 2012,
free-of-charge vaccinations for children attending nurseries were
introduced in Poland. Varicella vaccination coverage in this
population is far from advised, as it may lead to a change in the
varicella incidence pattern in the next years. Lower rates of varicella
cases may lead to weaker stimulation of cellular immunity and a
higher incidence of herpes zoster in children who have had a
varicella infection. The two strategies that are cost-effective in
reducing varicella cases are early immunization, including children
less than 1 year of age, and adolescent immunization.25–27
The analysis of deﬁned population-based hospital discharge data
appears to be a feasible, simple, and potentially sensitive way to
monitor varicella complications. However, there are several
limitations to the use of such data. The number of severe cases is
reliable but the number of less severe cases may be underestimated,
as many complications are managed at the primary care level. The
decision for hospitalization is based on the clinical judgment of the
primary care physician as there are no strict referral criteria.
In conclusion, most children hospitalized with varicella compli-
cations were immunologically healthy, and the most frequent
causes of admission were complications involving the respiratory
tract. Our results indicate that the type of varicella complication
depends on the patient’s age, with meningoencephalitis more
common in older children (>6 years of age). Although the peak
incidence of varicella is among patients aged 4–5 years, the highest
hospitalization rate is in the youngest age group, in which
vaccination cannot be used. The only way to protect these infants
is to perform routine population vaccination and to decrease the
probability of coming into contact with the virus during the ﬁrst year
of life. The presented results should remind parents and doctors that
varicella may to lead to severe, potentially life-threatening
complications in unvaccinated children and adolescents, and may
also demonstrate the beneﬁts of varicella vaccination.
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